While promoting the material happiness and mental wellness of our employees, we also use creativity and take effort to contribute to everyone's health.
Enacted: April 1, 2011- Manufacturing for 109 Years, Established for 78 Years -
- Manufacturing for 109 Years, Established for 78 Years -
March 30, 2023
Shinsei Pharmaceutical Co., Ltd.
Tokusuke Kajitani, President and Representative Director
While promoting the material happiness and mental wellness of our employees, we also use creativity and take effort to contribute to everyone's health.
Enacted: April 1, 2011
1
Willingness to Learn
We use creativity and ample research to challenge ourselves with new goals.
2
Determination
We recognize self-responsibility and the need to move relentlessly forward.
3
Gratitude
We express our gratitude by contributing to the society.
Name |
SHINSEI PHARM. INDUST. CO.,LTD |
Office/Factory Location |
ZIP:635-0103 1269 Shimizutani, Takatori-cho, Takaichi-gun, Nara, Japan. |
Factory Location |
ZIP:635-0103 313-1 Shimizutani, Takatori-cho, Takaichi-gun, Nara, Japan |
Establishment |
January 1947 |
Capital |
¥36,000,000 |
Representative Director |
Norisuke Kajitani |
Businesses |
R＆D・manufacturing（formulation・Packaging）・selling of OTC （General） |
Major Trading Partners |
Kaigen Pharma Co., Ltd. / Kracie Pharma, Ltd. / Kowa Company,Ltd / KOBAYASHI Pharmaceutical Co., Ltd. / Sato Pharmaceutical Co., Ltd / JFRONTIER inc. / CEOLIA Pharma Co. Ltd / Zenyaku Kogyo Company, Ltd. / DAIICHI SANKYO HEALTHCARE CO., LTD. / Chukyoiyakuhin Co., Ltd. / TSUMURA CO., LTD. / TOKIWA Pharmaceutical Co. ,Ltd / TOA Pharmaceuticals Co., Ltd. / Nippon Zoki Pharmaceutical Co., Ltd./ Other (in alphabetical order) |
Banks |
Nanto Bank, Mitsubishi UFJ Bank, Chukyo Bank, Kyoto Bank, Japan Finance Corporation (JFC) |
1894 |
Kajitani Ejiro's father started his pharmaceutical business (Enjudo Yakubo). |
1914 |
Kajitani Ejiro's father started the production of medicine. |
January
1947 |
The name of the company was changed from the former Kajitani Enjudo to the present name when it was incorporated with a capital of 1 million yen. Keizo Kajitani became the first Representative Director. |
October
1972 |
Vitamin E Formulation "ALPHAE E" released. |
September
1973 |
A plant was newly built in the present place. |
June
1979 |
An extension and reconstruction to the plant was built based on GMP Standard. |
October
1980 |
The capital was increased to 4 million yen. |
October
1983 |
The capital was increased to 12 million yen. |
September
1986 |
Another extension to the plant was built, and a new section for raw herb extraction and the manufacturing line for orally consumed drug were made CACONAL-first Kanpo liquid formulation was manufactured. |
October
1986 |
CACONAL released. |
October
1987 |
Keizo Kajitani became an Executive. Yorihisa Kajitani became the Representative Director. |
October
1990 |
The capital was increased to 36 million Yen. |
December
1994 |
DRAMACH SP released. |
February
1996 |
The factory was remodeled based on GMP Standard. |
July
1996 |
To improve productivity, lines of Raw Herb Extraction, Filling and Wrapping were renewed. |
October
2001 |
CACONAL2 released. |
December
2003 |
Simultaneously acquired ISO9001/ISO14001 |
April
2005 |
TAKATORI factory was built based on GMP Standard ISO9001/ISO14001, and shifted location, the present place became the office. |
April
2007 |
Facilities for manufacturing solid drugs were upgraded. |
July
2007 |
Installed the horizontal cartoner for stick sachets. |
February
2011 |
Installed 8 consecutive R-cut packing machine of granulses, Spray dryer, Box-type dryer, 2 consecutive packing machine of Liquid, 1,200L tank. |
October
2015 |
Installed 2 color granules manufacturing equipment. |
November
2016 |
Installed pills manufacturing equipment. |
February
2017 |
Installed herbal extract equipment、 extract plant automation equipment. |
May
2017 |
Executive chairman:Yorihisa Kajitani |
June
2017 |
Manufacturing of jelly formulation begins |
January
2019 |
TAKATORI factory: Extension and reconstruction of the plant to adhere to the PIC/S |
June
2019 |
TAKATORI factory: Inspection completed by Taiwan FDA for PIC/S GMP |
August
2020 |
TAKATORI factory: Acquired PIC/S GMP certificate |
ZIP:635-0103 1269 Shimizutani, Takatori-cho, Takaichi-gun, Nara, Japan.
TEL:+81-744-52-3330
ZIP:635-0103 313-1 Shimizutani, Takatori-cho, Takaichi-gun, Nara, Japan.
TEL:+81-744-52-1260
(LSA)A - a fuel with low sulfur content, is used for burning. Daily management and regular maintenances are also thoroughly done. In addition, we installed a deodorizing device as an accessory for the spray drying equipment.
Regarding the water purification project used during the manufacturing process, no water is being regenerated as pharmaceutical products do not make use of it.
Regarding other drainage systems, our current faciltiies will lessen the burden of river drainiage.
We are continuously improving the management of underground tanks・septic tanks, as well as the prevention of insects within the factory.
